The analysis revealed that in BRAF FOXE1+/− cancers, the decrease of all the analyzed thyroid differentiation markers is significantly more pronounced than that observed in BRAF FOXE1+/+ ones (Figure 4C), showing that lower FOXE1 levels are associated with less differentiated tumors. Here, FOXE1 is linked to cancer.